Partner Content Partner Content Interactive Pre-conference Workshop announced for Injectable... Workshop on Developing apps for Connected Drug Delivery
Partner Content Partner Content Janssen Pharmaceutical exclusive interview released ahead of... Janssen Pharmaceutical exclusive interview released
Events Partner Content Discover who’s speaking at Real-World Evidence 2020: Rare Di... Don’t miss your chance to attend:
Events Partner Content Real-World Evidence 2020: Rare Diseases and Innovative Thera... Explore practical applications of RWE in rare diseases
News Durect's post-op painkiller splits FDA advisory panel As the US opioid addiction crisis continues, it seems the FDA is less than convinced about the new painkilling drugs that the pharma industry is developing.
News Lilly bags FDA okay for Wegovy pill rival orforglipron Eli Lilly has claimed US approval for oral GLP-1 agonist orforglipron, setting up a market clash with Novo Nordisk's first-to-market Wegovy pill.
Sales & Marketing Sponsored Using AI-driven synthetic personas to take your insights fur... As AI continues to reshape the healthcare landscape, pharma teams are beginning to leverage synthetic personas.
